These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 3140498)
1. WHO Expert Committee on Leprosy. World Health Organ Tech Rep Ser; 1988; 768():1-51. PubMed ID: 3140498 [No Abstract] [Full Text] [Related]
2. Leprosy at a turning point? Harboe M Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):312-8. PubMed ID: 11221095 [No Abstract] [Full Text] [Related]
3. Dapsone drug resistance in the MDT era. Roche PW; Neupane KD; Failbus SS; Butlin CR Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):323-5. PubMed ID: 11221097 [No Abstract] [Full Text] [Related]
4. A quantitative basis for sustainable anti-Mycobacterium leprae chemotherapy in leprosy control programs. Almeida JG Int J Lepr Other Mycobact Dis; 1992 Jun; 60(2):255-68. PubMed ID: 1522367 [No Abstract] [Full Text] [Related]
5. Multi-drug therapy in leprosy. Girdhar BK Indian J Lepr; 1987; 59(2):145-51. PubMed ID: 3309084 [No Abstract] [Full Text] [Related]
6. [New trends in the treatment of leprosy]. Koźmińska-Kubarska A Pol Tyg Lek; 1983 Nov; 38(46):1439-41. PubMed ID: 6374636 [No Abstract] [Full Text] [Related]
7. Progress in the chemotherapy of leprosy. Grosset JH Int J Lepr Other Mycobact Dis; 1994 Jun; 62(2):268-77. PubMed ID: 8046266 [No Abstract] [Full Text] [Related]
8. Concepts behind the development of multiple drug therapy regimens in leprosy. Waters MF Ethiop Med J; 1986 Dec; 24 Suppl 1():61-7. PubMed ID: 3301333 [No Abstract] [Full Text] [Related]
9. Problems of multidrug therapy. Ramu G Indian J Lepr; 1991; 63(3-4):435-45. PubMed ID: 1804896 [No Abstract] [Full Text] [Related]
10. [Drug resistance of Mycobacterium leprae]. Pattyn SR Acta Leprol; 1986; 4(3):279-87. PubMed ID: 3551466 [No Abstract] [Full Text] [Related]
11. Epidemiology of leprosy in relation to control. Report of a WHO Study Group. World Health Organ Tech Rep Ser; 1985; 716():1-60. PubMed ID: 3925646 [No Abstract] [Full Text] [Related]
12. Multidrug therapy--the pathway for global leprosy elimination. al-Qubati Y; al-Kubati AS Indian J Lepr; 2000; 72(4):477-90. PubMed ID: 11212482 [TBL] [Abstract][Full Text] [Related]
13. Prospects for chemotherapy of leprosy. Ji B Indian J Lepr; 2000; 72(2):187-98. PubMed ID: 11008659 [No Abstract] [Full Text] [Related]
14. WHO global strategy for further reducing the leprosy burden and sustaining leprosy control activities (Plan period: 2006-2010). World Health Organization Indian J Lepr; 2006; 78(1):7-31. PubMed ID: 16646281 [No Abstract] [Full Text] [Related]
15. An update on the diagnosis and treatment of leprosy. Moschella SL J Am Acad Dermatol; 2004 Sep; 51(3):417-26. PubMed ID: 15337986 [No Abstract] [Full Text] [Related]
16. WHO regional strategy for sustaining leprosy services and further reducing the burden of leprosy, 2006-2010. WHO Regional Office for South-East Asia Indian J Lepr; 2006; 78(1):33-47. PubMed ID: 16646282 [No Abstract] [Full Text] [Related]
17. Does dapsone resistance really matter in the MDT era? Ji B Int J Lepr Other Mycobact Dis; 2001 Mar; 69(1):54-5. PubMed ID: 11480322 [No Abstract] [Full Text] [Related]
18. Single-dose treatment for paucibacillary leprosy; clinical problems and management. Pai VV; Bulchand HO; Revankar CR; Ganapati R Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):310-2. PubMed ID: 10575414 [No Abstract] [Full Text] [Related]
19. Search for effective short-course regimens for the treatment of leprosy. Pattyn SR Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):76-81. PubMed ID: 8326183 [No Abstract] [Full Text] [Related]
20. [Antibacterial chemotherapy in leprosy: principles, objectives and recommendations]. Sansarricq H Acta Leprol; 1986; 4(3):355-62. PubMed ID: 3551474 [No Abstract] [Full Text] [Related] [Next] [New Search]